These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 8124260

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
    Hsieh MH, Varadi G, Flomenberg N, Korngold R.
    Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
    [Abstract] [Full Text] [Related]

  • 23. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M, Steinmann J, Petrela E, Hartung G, Schmitz N, Uharek L.
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood.
    Harris DT.
    Bone Marrow Transplant; 1995 Jan; 15(1):17-23. PubMed ID: 7742753
    [Abstract] [Full Text] [Related]

  • 26. [Study of experimental mixed bone marrow transplantation].
    Luo H, Yang P, He F.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):418-21. PubMed ID: 11189509
    [Abstract] [Full Text] [Related]

  • 27. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

  • 28. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y, Wang HH, Wang M, Zhou Z, Zhai WJ, Huang Y, Jiang EL, Wang ZD, Zhou SY, Liu QG, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [Abstract] [Full Text] [Related]

  • 29. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S, Yacovlev E, Gelfand Y, Vilensky A, Slavin S.
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [Abstract] [Full Text] [Related]

  • 30. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE.
    J Immunol; 1996 Dec 01; 157(11):4811-21. PubMed ID: 8943383
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.
    Blazar BR, Taylor PA, Boyer MW, Panoskaltsis-Mortari A, Allison JP, Vallera DA.
    J Immunol; 1997 Oct 01; 159(7):3460-73. PubMed ID: 9317145
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD, Mori S, Mann S, Savary CA, Mullen CA.
    Cancer Res; 2000 Oct 15; 60(20):5797-802. PubMed ID: 11059776
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice.
    Vourka-Karussis U, Karussis D, Ackerstein A, Slavin S.
    Exp Hematol; 1995 Mar 15; 23(3):196-201. PubMed ID: 7875238
    [Abstract] [Full Text] [Related]

  • 39. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 15; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 40. [The action of donor-derived NK cell in leukemic mice MHC haplotype-mismatched bone marrow transplantation].
    Wang CY, Tan H, Guo KY.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 15; 30(2):107-10. PubMed ID: 19563021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.